Clinical Trial

A Phase 1 Study of Navlimetostat Tablet Formulations

Name: A Phase 1 Study of Navlimetostat Tablet Formulations — clinical trial record (NCT07544628)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study aims to compare the PK of Navlimetostat after administration of a wet-granulation tablet versus the dry-granulation tablet formulation in healthy adult female

Protocol Amendment History 2 changes

critical Recruitment opened 2026-05-15

notable Trial sites expanded: 0 -> 3 locations 2026-05-15

Trial Details

NCT Number	NCT07544628
Lead Sponsor	Bristol-Myers Squibb
Conditions	Healthy Participants
Enrollment	64 participants
Start Date	2026-04-27
Primary Completion	2026-08-31 (estimated)
Study Completion	2026-10-15 (estimated)
Updated on ClinicalTrials.gov	2026-06-24